
Novartis AG
SIX:NOVN

Novartis AG?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
84.52
102.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Novartis AG hold over its rivals?
What risks and challenges
does Novartis AG face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Novartis AG.
Provide an overview of the primary business activities
of Novartis AG.
What unique competitive advantages
does Novartis AG hold over its rivals?
What risks and challenges
does Novartis AG face in the near future?
Has there been any significant insider trading activity
in Novartis AG recently?
Summarize the latest earnings call
of Novartis AG.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Novartis AG.
Provide P/S
for Novartis AG.
Provide P/E
for Novartis AG.
Provide P/OCF
for Novartis AG.
Provide P/FCFE
for Novartis AG.
Provide P/B
for Novartis AG.
Provide EV/S
for Novartis AG.
Provide EV/GP
for Novartis AG.
Provide EV/EBITDA
for Novartis AG.
Provide EV/EBIT
for Novartis AG.
Provide EV/OCF
for Novartis AG.
Provide EV/FCFF
for Novartis AG.
Provide EV/IC
for Novartis AG.
Show me price targets
for Novartis AG made by professional analysts.
What are the Revenue projections
for Novartis AG?
How accurate were the past Revenue estimates
for Novartis AG?
What are the Net Income projections
for Novartis AG?
How accurate were the past Net Income estimates
for Novartis AG?
What are the EPS projections
for Novartis AG?
How accurate were the past EPS estimates
for Novartis AG?
What are the EBIT projections
for Novartis AG?
How accurate were the past EBIT estimates
for Novartis AG?
Compare the revenue forecasts
for Novartis AG with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Novartis AG and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Novartis AG against its competitors.
Analyze the profit margins
(gross, operating, and net) of Novartis AG compared to its peers.
Compare the P/E ratios
of Novartis AG against its peers.
Discuss the investment returns and shareholder value creation
comparing Novartis AG with its peers.
Analyze the financial leverage
of Novartis AG compared to its main competitors.
Show all profitability ratios
for Novartis AG.
Provide ROE
for Novartis AG.
Provide ROA
for Novartis AG.
Provide ROIC
for Novartis AG.
Provide ROCE
for Novartis AG.
Provide Gross Margin
for Novartis AG.
Provide Operating Margin
for Novartis AG.
Provide Net Margin
for Novartis AG.
Provide FCF Margin
for Novartis AG.
Show all solvency ratios
for Novartis AG.
Provide D/E Ratio
for Novartis AG.
Provide D/A Ratio
for Novartis AG.
Provide Interest Coverage Ratio
for Novartis AG.
Provide Altman Z-Score Ratio
for Novartis AG.
Provide Quick Ratio
for Novartis AG.
Provide Current Ratio
for Novartis AG.
Provide Cash Ratio
for Novartis AG.
What is the historical Revenue growth
over the last 5 years for Novartis AG?
What is the historical Net Income growth
over the last 5 years for Novartis AG?
What is the current Free Cash Flow
of Novartis AG?
Discuss the annual earnings per share (EPS)
trend over the past five years for Novartis AG.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
CH |
![]() |
Novartis AG
SIX:NOVN
|
195.1B CHF | 4.3 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
770.8B USD | 17.1 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
391.9B USD | 4.4 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.4T DKK | 8.1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
243.8B CHF | 4.2 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
186B GBP | 4.4 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
239.5B USD | 3.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
158.2B USD | 68.2 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
145.7B USD | 2.3 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
132.5B EUR | 3 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
CH |
![]() |
Novartis AG
SIX:NOVN
|
Average P/S:
63.5
4.3
|
3%
|
1.4 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
17.1
|
22%
|
0.8 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
578.3
|
9%
|
64.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
4.4
|
3%
|
1.5 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
8.1
|
17%
|
0.5 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
4.2
|
5%
|
0.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
4.4
|
7%
|
0.6 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
3.7
|
5%
|
0.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
68.2
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
2.3
|
0%
|
N/A |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
3
|
6%
|
0.5 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.